MedMij:V1.0 AddendaInhoudelijkeGegevens: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
(support for date T) |
k |
||
Regel 38: | Regel 38: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_1_MA_1 | + | |style="background-color: white;"|MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 47: | Regel 47: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geannuleerd indicator | |colspan="3"|Geannuleerd indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 82: | Regel 82: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_1_MA_2 | + | |style="background-color: white;"|MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 91: | Regel 91: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 123: | Regel 123: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MA_2 | + | |style="background-color: white;"|MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 135: | Regel 135: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 170: | Regel 170: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_3_MA_1 | + | |style="background-color: white;"|MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 182: | Regel 182: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 217: | Regel 217: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_MA_1 | + | |style="background-color: white;"|MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 226: | Regel 226: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 272: | Regel 272: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_VV_2 | + | |style="background-color: white;"|MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Datum | |colspan="3"|Datum | ||
Regel 278: | Regel 278: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Te verstrekken hoeveelheid | |colspan="3"|Te verstrekken hoeveelheid | ||
Regel 290: | Regel 290: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toelichting | |colspan="3"|Toelichting | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|nog in te vullen, zie word... |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
Regel 306: | Regel 306: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_VV_1 | + | |style="background-color: white;"|MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Datum | |colspan="3"|Datum | ||
Regel 312: | Regel 312: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Te verstrekken hoeveelheid | |colspan="3"|Te verstrekken hoeveelheid | ||
Regel 345: | Regel 345: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_1_TA_1 | + | |style="background-color: white;"|MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 354: | Regel 354: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geannuleerd indicator | |colspan="3"|Geannuleerd indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
Regel 389: | Regel 389: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_TA_1 | + | |style="background-color: white;"|MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 433: | Regel 433: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_TA_1 | + | |style="background-color: white;"|MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 482: | Regel 482: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MVE_1 | + | |style="background-color: white;"|MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Aanschrijfdatum | |colspan="3"|Aanschrijfdatum | ||
Regel 510: | Regel 510: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_MVE_1 | + | |style="background-color: white;"|MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Datum | |colspan="3"|Datum | ||
Regel 549: | Regel 549: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MGB_1 | + | |style="background-color: white;"|MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 555: | Regel 555: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 561: | Regel 561: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
Regel 583: | Regel 583: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
Regel 596: | Regel 596: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MGB_2 | + | |style="background-color: white;"|MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 602: | Regel 602: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 608: | Regel 608: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
Regel 630: | Regel 630: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Informant | |colspan="3"|Informant | ||
− | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | + | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
Regel 646: | Regel 646: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MGB_3 | + | |style="background-color: white;"|MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 652: | Regel 652: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 677: | Regel 677: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Informant | |colspan="3"|Informant | ||
− | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
Regel 693: | Regel 693: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|T, om 20:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
Regel 712: | Regel 712: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 737: | Regel 737: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_3_MGB_1 | + | |style="background-color: white;"|MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 743: | Regel 743: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 749: | Regel 749: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
Regel 784: | Regel 784: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_MGB_1 | + | |style="background-color: white;"|MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 790: | Regel 790: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Volgens afspraak indicator | |colspan="3"|Volgens afspraak indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|false |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 833: | Regel 833: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgegevens | |colspan="3"|Naamgegevens | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|J. XXX_Amaya |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Patient identificatienummer | |colspan="3"|Patient identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911764 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Patient identificatienummer | |colspan="3"|Patient identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geboortedatum | |colspan="3"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 aug 1964 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geslacht | |colspan="3"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
|}<section end=XXX_Bourgonje /> | |}<section end=XXX_Bourgonje /> | ||
===Medicatieafspraken XXX_Bourgonje === | ===Medicatieafspraken XXX_Bourgonje === | ||
Regel 857: | Regel 857: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 1 dag, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 872: | Regel 875: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 903: | Regel 901: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T, om 09:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 936: | Regel 942: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar afspraak of gebruik: TA | ||
+ | |style="background-color: white;"|MBH_513_2_TA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 982: | Regel 989: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T, om 14:32 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 28 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar afspraak of gebruik: MGB | ||
+ | |style="background-color: white;"|MBH_513_3_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden van voorschrijven |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |rowspan="4"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per week 5 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.012: | Regel 1.036: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Lichaamslengte |
− | |style="background-color: white;"| | + | |style="background-color: white;"|155 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Lichaamsgewicht | ||
+ | |style="background-color: white;"|54 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende informatie | ||
+ | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|In overleg met specialist |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |}<section end= | + | |}<section end=MA_XXX_Bourgonje /> |
− | == | + | ===Verstrekkingsverzoeken XXX_Bourgonje === |
− | <section begin= | + | <section begin=VV_XXX_Bourgonje /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.057: | Regel 1.090: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-08-16T14:32:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | === | + | |colspan="3"|Beoogd verstrekker |
− | + | |style="background-color: white;"|Apotheek De Gulle Gaper | |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|nog in te vullen, zie word... | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_513_2_MA_2 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_513_2 | ||
+ | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.082: | Regel 1.125: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|40 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afleverlocatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisadres patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende wensen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=VV_XXX_Bourgonje /> |
+ | ===Toedieningsafspraken XXX_Bourgonje === | ||
+ | <section begin=TA_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.123: | Regel 1.164: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 12:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geannuleerd indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.148: | Regel 1.186: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_513_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.167: | Regel 1.208: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 7 dagen, om 14:52 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.211: | Regel 1.252: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:45 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Aanvullende | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende informatie | ||
+ | |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Wegens niet leverbaar zijn van Broxil |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=TA_XXX_Bourgonje /> |
+ | ===Verstrekkingen XXX_Bourgonje === | ||
+ | <section begin=MVE_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.258: | Regel 1.301: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aanschrijfdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_513_2_VV_2 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.299: | Regel 1.329: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:45 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Afleverlocatie |
+ | |style="background-color: white;"|Huisadres patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=MVE_XXX_Bourgonje /> |
+ | ===Medicatiegebruik XXX_Bourgonje === | ||
+ | <section begin=MGB_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.340: | Regel 1.368: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 2 dagen, om 15:39 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.362: | Regel 1.390: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_2_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.381: | Regel 1.415: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 20:40 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.403: | Regel 1.437: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_2_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.424: | Regel 1.465: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 21:39 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.443: | Regel 1.484: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.465: | Regel 1.512: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 20:59 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.487: | Regel 1.531: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde verstrekking | ||
+ | |style="background-color: white;"|MBH_5132_2_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.509: | Regel 1.556: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 3 dagen, om 20:59 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden gebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Lymfekanker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.553: | Regel 1.603: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 4 dagen, om 22:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|false |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|MBH identificatie | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_513_4 | ||
+ | |}<section end=MGB_XXX_Bourgonje /> | ||
+ | ==Patiënt J. XXX_Cnossen== | ||
+ | <section begin=XXX_Cnossen /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|J. XXX_Amaya | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|999911764 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geboortedatum | ||
+ | |style="background-color: white;"|6 aug 1964 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geslacht | ||
+ | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | ||
+ | |}<section end=XXX_Cnossen /> | ||
+ | ===Medicatieafspraken XXX_Cnossen === | ||
+ | <section begin=MA_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.600: | Regel 1.676: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 1 dag, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.619: | Regel 1.701: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 maal per dag 1 stuk |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.641: | Regel 1.720: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.663: | Regel 1.742: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.685: | Regel 1.761: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar afspraak of gebruik: TA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_TA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.704: | Regel 1.786: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.726: | Regel 1.808: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar afspraak of gebruik: MGB |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden van voorschrijven | ||
+ | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.748: | Regel 1.836: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per week 5 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.772: | Regel 1.855: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.794: | Regel 1.877: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Lichaamslengte |
− | |style="background-color: white;"| | + | |style="background-color: white;"|155 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Lichaamsgewicht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|54 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|MBH identificatie | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|In overleg met specialist | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_513_4 | ||
+ | |}<section end=MA_XXX_Cnossen /> | ||
+ | ===Toedieningsafspraken XXX_Cnossen === | ||
+ | <section begin=TA_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.819: | Regel 1.910: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T, om 12:25 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geannuleerd indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.844: | Regel 1.932: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_513_1_MA_2 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.869: | Regel 1.954: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 7 dagen, om 14:52 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Opname | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_513_2_MA_1 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.919: | Regel 1.998: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 5 dagen, om 09:45 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Wegens niet leverbaar zijn van Broxil |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=TA_XXX_Cnossen /> |
+ | ===Medicatiegebruik XXX_Cnossen === | ||
+ | <section begin=MGB_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
Regel 1.972: | Regel 2.047: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 2 dagen, om 15:39 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.994: | Regel 2.069: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
Regel 2.003: | Regel 2.078: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gerelateerde afspraak : MA | |colspan="3"|Gerelateerde afspraak : MA | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.019: | Regel 2.094: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|T, om 20:40 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.044: | Regel 2.116: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
Regel 2.053: | Regel 2.125: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gerelateerde afspraak : MA | |colspan="3"|Gerelateerde afspraak : MA | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.069: | Regel 2.144: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|T, om 21:39 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T, tot nader order |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.091: | Regel 2.163: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
Regel 2.100: | Regel 2.172: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gerelateerde afspraak : MA | |colspan="3"|Gerelateerde afspraak : MA | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.116: | Regel 2.191: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|T, om 20:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.141: | Regel 2.210: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Gerelateerde | + | |colspan="3"|Gerelateerde verstrekking |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MVE_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
Regel 2.156: | Regel 2.225: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.167: | Regel 2.234: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 3 dagen, om 20:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|MBH identificatie | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden gebruik | ||
+ | |style="background-color: white;"|Lymfekanker | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_513_3 | ||
+ | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.233: | Regel 2.282: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 4 dagen, om 22:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|false |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.255: | Regel 2.304: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_4_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=MGB_XXX_Cnossen /> |
+ | ==Patiënt R. XXX_Dirksz== | ||
+ | <section begin=XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.273: | Regel 2.330: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|J. XXX_Amaya |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911764 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Gebruiksperiode | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geboortedatum | ||
+ | |style="background-color: white;"|6 aug 1964 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geslacht | ||
+ | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | ||
+ | |}<section end=XXX_Dirksz /> | ||
+ | ===Medicatieafspraken XXX_Dirksz === | ||
+ | <section begin=MA_XXX_Dirksz /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 1 dag, om 11:25 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 2.289: | Regel 2.373: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.296: | Regel 2.380: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.317: | Regel 2.399: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.348: | Regel 2.440: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar afspraak of gebruik: TA | ||
+ | |style="background-color: white;"|MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.379: | Regel 2.487: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar afspraak of gebruik: MGB |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden van voorschrijven |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="4"|Gebruiksinstructie | |
− | |||
− | |||
− | |style=" | ||
− | |||
− | |colspan=" | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |rowspan="4"| | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.453: | Regel 2.534: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.472: | Regel 2.556: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Lichaamslengte | ||
+ | |style="background-color: white;"|155 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Lichaamsgewicht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|54 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|MBH identificatie | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | {| class="wikitable" width="85%" | + | |colspan="3"|Toelichting |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: white;"|In overleg met specialist |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_513_4 | ||
+ | |}<section end=MA_XXX_Dirksz /> | ||
+ | ===Verstrekkingsverzoeken XXX_Dirksz === | ||
+ | <section begin=VV_XXX_Dirksz /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.494: | Regel 2.589: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-08-16T14:32:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|nog in te vullen, zie word... |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.537: | Regel 2.623: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Datum | |colspan="3"|Datum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|40 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Beoogd verstrekker | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Relatie naar | + | |colspan="3"|Afleverlocatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisadres patiënt |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende wensen | ||
+ | |style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_513_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=VV_XXX_Dirksz /> |
+ | ===Toedieningsafspraken XXX_Dirksz === | ||
+ | <section begin=TA_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.565: | Regel 2.662: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T, om 12:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar medicatieafspraak | |
− | + | |style="background-color: white;"|MBH_513_1_MA_2 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|Relatie naar | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.623: | Regel 2.706: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 7 dagen, om 14:52 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.645: | Regel 2.728: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_513_2_MA_1 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.670: | Regel 2.750: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:45 |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.695: | Regel 2.769: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende informatie | ||
+ | |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Wegens niet leverbaar zijn van Broxil |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=TA_XXX_Dirksz /> |
+ | ===Verstrekkingen XXX_Dirksz === | ||
+ | <section begin=MVE_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.720: | Regel 2.799: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aanschrijfdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_513_2_VV_2 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.768: | Regel 2.826: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 5 dagen, om 09:45 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') |
− | |}<section end= | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | === | + | |colspan="3"|Afleverlocatie |
− | <section begin= | + | |style="background-color: white;"|Huisadres patiënt |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende informatie | ||
+ | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_513_4_VV_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_513_4 | ||
+ | |}<section end=MVE_XXX_Dirksz /> | ||
+ | ===Medicatiegebruik XXX_Dirksz === | ||
+ | <section begin=MGB_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.793: | Regel 2.866: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 2 dagen, om 15:39 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.815: | Regel 2.888: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.821: | Regel 2.894: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_2_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.834: | Regel 2.913: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 20:40 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.859: | Regel 2.935: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.865: | Regel 2.941: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_2_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.878: | Regel 2.963: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 21:39 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.903: | Regel 2.982: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.909: | Regel 2.988: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|MBH identificatie | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | {| class="wikitable" width="85%" | + | |colspan="3"|Informant |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_513_2 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.922: | Regel 3.010: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 20:59 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.947: | Regel 3.029: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.953: | Regel 3.035: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde verstrekking | ||
+ | |style="background-color: white;"|MBH_5132_2_MVE_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.966: | Regel 3.054: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 3 dagen, om 20:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_3_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden gebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Lymfekanker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.012: | Regel 3.101: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 4 dagen, om 22:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|false |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|MBH identificatie | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_4_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_513_4 | ||
+ | |}<section end=MGB_XXX_Dirksz /> | ||
+ | ==Patiënt R. XXX_Gobee== | ||
+ | <section begin=XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.045: | Regel 3.149: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|J. XXX_Amaya |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911764 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 aug 1964 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
− | + | |}<section end=XXX_Gobee /> | |
− | + | ===Medicatieafspraken XXX_Gobee === | |
− | + | <section begin=MA_XXX_Gobee /> | |
− | | | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.080: | Regel 3.174: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 1 dag, om 11:25 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|true | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.113: | Regel 3.218: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.132: | Regel 3.240: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.138: | Regel 3.246: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.154: | Regel 3.259: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar afspraak of gebruik: TA | ||
+ | |style="background-color: white;"|MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.176: | Regel 3.284: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.182: | Regel 3.290: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.198: | Regel 3.306: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar afspraak of gebruik: MGB | ||
+ | |style="background-color: white;"|MBH_513_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden van voorschrijven | ||
+ | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.217: | Regel 3.334: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.223: | Regel 3.340: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.239: | Regel 3.353: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.261: | Regel 3.375: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.267: | Regel 3.381: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Lichaamslengte |
− | |style="background-color: white;"| | + | |style="background-color: white;"|155 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Lichaamsgewicht | ||
+ | |style="background-color: white;"|54 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende informatie | ||
+ | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=MA_XXX_Gobee /> |
+ | ===Verstrekkingsverzoeken XXX_Gobee === | ||
+ | <section begin=VV_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.283: | Regel 3.408: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-08-16T14:32:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|nog in te vullen, zie word... |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.326: | Regel 3.442: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Datum | |colspan="3"|Datum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Beoogd verstrekker | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afleverlocatie | ||
+ | |style="background-color: white;"|Huisadres patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende wensen | ||
+ | |style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Relatie naar | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=VV_XXX_Gobee /> |
+ | ===Toedieningsafspraken XXX_Gobee === | ||
+ | <section begin=TA_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.354: | Regel 3.481: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T, om 12:25 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Relatie naar | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_513_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.382: | Regel 3.525: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 7 dagen, om 14:52 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Relatie naar | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.415: | Regel 3.569: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:45 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.437: | Regel 3.588: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.443: | Regel 3.594: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Wegens niet leverbaar zijn van Broxil |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|MBH identificatie | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_513_4 | ||
+ | |}<section end=TA_XXX_Gobee /> | ||
+ | ===Verstrekkingen XXX_Gobee === | ||
+ | <section begin=MVE_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.462: | Regel 3.618: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aanschrijfdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_513_2_VV_2 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.509: | Regel 3.646: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:45 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Afleverlocatie |
+ | |style="background-color: white;"|Huisadres patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_513_4_VV_1 | |
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=MVE_XXX_Gobee /> |
+ | ===Medicatiegebruik XXX_Gobee === | ||
+ | <section begin=MGB_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
Regel 3.553: | Regel 3.685: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 2 dagen, om 15:39 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.575: | Regel 3.707: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.581: | Regel 3.713: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gerelateerde afspraak : MA | |colspan="3"|Gerelateerde afspraak : MA | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 3.600: | Regel 3.732: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 20:40 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.622: | Regel 3.754: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.631: | Regel 3.763: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gerelateerde afspraak : MA | |colspan="3"|Gerelateerde afspraak : MA | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.648: | Regel 3.781: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T, om 21:39 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.695: | Regel 3.801: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_2_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
Regel 3.716: | Regel 3.829: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 20:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.735: | Regel 3.848: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde verstrekking | ||
+ | |style="background-color: white;"|MBH_5132_2_MVE_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
Regel 3.747: | Regel 3.863: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.758: | Regel 3.872: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 3 dagen, om 20:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="4"|Gebruiksinstructie | |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |rowspan="3"| | |
− | |style="background-color: # | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="background-color: # | + | |colspan="2"|Omschrijving |
− | |colspan=" | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden gebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Lymfekanker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.807: | Regel 3.920: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 4 dagen, om 22:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|false |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.829: | Regel 3.942: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.835: | Regel 3.948: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_4_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=MGB_XXX_Gobee /> |
+ | ==Patiënt J. XXX_Kilkenny== | ||
+ | <section begin=XXX_Kilkenny /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|J. XXX_Amaya | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|999911764 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geboortedatum | ||
+ | |style="background-color: white;"|6 aug 1964 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geslacht | ||
+ | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | ||
+ | |}<section end=XXX_Kilkenny /> | ||
+ | ===Medicatieafspraken XXX_Kilkenny === | ||
+ | <section begin=MA_XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
Regel 3.848: | Regel 3.993: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om 11:25 | + | |style="background-color: white;"|T- 1 dag, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 3.863: | Regel 4.011: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.870: | Regel 4.018: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 3.889: | Regel 4.037: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 3.904: | Regel 4.052: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G- | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.911: | Regel 4.059: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.917: | Regel 4.065: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 3.930: | Regel 4.078: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T, tot nader order |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar afspraak of gebruik: TA | ||
+ | |style="background-color: white;"|MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 3.974: | Regel 4.125: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar afspraak of gebruik: MGB | ||
+ | |style="background-color: white;"|MBH_513_3_MGB_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden van voorschrijven | ||
+ | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.996: | Regel 4.153: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.002: | Regel 4.159: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.015: | Regel 4.172: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om 09:35 | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 4.030: | Regel 4.187: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Lichaamslengte | ||
+ | |style="background-color: white;"|155 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Lichaamsgewicht | ||
+ | |style="background-color: white;"|54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|In overleg met specialist |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=MA_XXX_Kilkenny /> |
+ | ===Medicatiegebruik XXX_Kilkenny === | ||
+ | <section begin=MGB_XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.062: | Regel 4.227: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 2 dagen, om 15:39 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.084: | Regel 4.249: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_2_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.103: | Regel 4.274: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 20:40 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.150: | Regel 4.324: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 21:39 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.172: | Regel 4.343: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.178: | Regel 4.349: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_2_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.191: | Regel 4.371: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 20:59 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.219: | Regel 4.396: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde verstrekking |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MVE_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.235: | Regel 4.415: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 3 dagen, om 20:59 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden gebruik |
− | + | |style="background-color: white;"|Lymfekanker | |
− | |||
− | | | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.285: | Regel 4.462: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 4 dagen, om 22:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|false |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.307: | Regel 4.484: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.313: | Regel 4.490: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_4_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=MGB_XXX_Kilkenny /> |
+ | ==Patiënt R. XXX_Ruys== | ||
+ | <section begin=XXX_Ruys /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.325: | Regel 4.510: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|J. XXX_Amaya |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911764 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 aug 1964 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
− | | | + | |}<section end=XXX_Ruys /> |
− | + | ==Patiënt R. XXX_Strengersz== | |
− | |style="background-color: white;"| | + | <section begin=XXX_Strengersz /> |
− | |-style=" | + | {| class="wikitable" width="85%" |
− | |colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt |
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Naamgegevens |
+ | |style="background-color: white;"|J. XXX_Amaya | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911764 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|6 aug 1964 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
− | |} | + | |}<section end=XXX_Strengersz /> |
+ | ===Medicatieafspraken XXX_Strengersz === | ||
+ | <section begin=MA_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
Regel 4.367: | Regel 4.559: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 1 dag, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 4.382: | Regel 4.577: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.389: | Regel 4.584: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|10 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.408: | Regel 4.603: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 09:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 4.420: | Regel 4.618: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.427: | Regel 4.625: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.446: | Regel 4.644: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot nader order |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar afspraak of gebruik: TA | ||
+ | |style="background-color: white;"|MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Geneesmiddel | |
− | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"| | ||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.508: | Regel 4.669: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.529: | Regel 4.691: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 14:32 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar afspraak of gebruik: MGB |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Reden afspraak |
+ | |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden van voorschrijven |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | || | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Toedieningsweg |
− | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |
− | | | ||
− | | | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Doseerinstructie |
− | + | |style="background-color: white;"|1 maal per week 5 stuks | |
− | |||
− | |||
− | |||
− | | | ||
− | |style="background-color: white;"|1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.605: | Regel 4.738: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.624: | Regel 4.760: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.630: | Regel 4.766: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Lichaamslengte | ||
+ | |style="background-color: white;"|155 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Lichaamsgewicht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|54 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aanvullende informatie | ||
+ | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toelichting | ||
+ | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=MA_XXX_Strengersz /> |
+ | ===Verstrekkingsverzoeken XXX_Strengersz === | ||
+ | <section begin=VV_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.646: | Regel 4.793: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-08-16T14:32:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | + | |style="background-color: white;"|nog in te vullen, zie word... | |
− | |||
− | | | ||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.687: | Regel 4.827: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 5 dagen, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|40 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Afleverlocatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisadres patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende wensen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=VV_XXX_Strengersz /> |
+ | ===Toedieningsafspraken XXX_Strengersz === | ||
+ | <section begin=TA_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
Regel 4.728: | Regel 4.866: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 12:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geannuleerd indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
Regel 4.740: | Regel 4.881: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.772: | Regel 4.910: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 7 dagen, om 14:52 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Opname | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.791: | Regel 4.932: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.797: | Regel 4.938: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.813: | Regel 4.954: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om 09: | + | |style="background-color: white;"|T- 5 dagen, om 09:45 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
Regel 4.825: | Regel 4.966: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Wegens niet leverbaar zijn van Broxil |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | |} | + | |}<section end=TA_XXX_Strengersz /> |
+ | ===Verstrekkingen XXX_Strengersz === | ||
+ | <section begin=MVE_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.860: | Regel 5.003: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aanschrijfdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 14:32 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Geneesmiddel |
+ | |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_513_2_VV_2 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|Relatie naar | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.901: | Regel 5.031: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T, om 09: | + | |style="background-color: white;"|T- 5 dagen, om 09:45 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Afleverlocatie |
+ | |style="background-color: white;"|Huisadres patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
− | | | + | |}<section end=MVE_XXX_Strengersz /> |
− | + | ===Medicatiegebruik XXX_Strengersz === | |
− | + | <section begin=MGB_XXX_Strengersz /> | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.948: | Regel 5.070: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 2 dagen, om 15:39 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, tot nader order | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.967: | Regel 5.092: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal | + | |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.973: | Regel 5.098: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.989: | Regel 5.117: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 20:40 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, tot nader order | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot nader order, | + | |style="background-color: white;"|Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 5.014: | Regel 5.145: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Informant | ||
+ | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.033: | Regel 5.167: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 21:39 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|true | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot nader order |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Informant |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.083: | Regel 5.214: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 20:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 5.102: | Regel 5.233: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 5.108: | Regel 5.239: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde verstrekking |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MVE_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.124: | Regel 5.258: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 3 dagen, om 20:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_513_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden gebruik |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Lymfekanker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.165: | Regel 5.305: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 4 dagen, om 22:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|true |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|false | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 6.190: | Regel 5.327: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gerelateerde afspraak : MA | |colspan="3"|Gerelateerde afspraak : MA | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
Regel 6.205: | Regel 5.342: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_513_4 |
|}<section end=MGB_XXX_Strengersz /> | |}<section end=MGB_XXX_Strengersz /> |
Versie van 8 okt 2018 14:11
Deze pagina is nog in bewerking |
Addenda voor inhoudelijke gegevens
Patiënt J. XXX_Amaya
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Amaya
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 1 dag, om 11:25 | ||
Gebruiksperiode | Vanaf T- 1 dag, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 10 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 09:00 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 5 dagen, om 09:35 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Lichaamslengte | 155 | ||
Lichaamsgewicht | 54 | ||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_513_4 |
Verstrekkingsverzoeken XXX_Amaya
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | 2018-08-16T14:32:00 | ||
Auteur | Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
Te verstrekken hoeveelheid | 30 stuks | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Toelichting | nog in te vullen, zie word... | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | T- 5 dagen, om 09:35 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 40 stuks | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende wensen | Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Toedieningsafspraken XXX_Amaya
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T, om 12:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||
MBH identificatie | MBH_513_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 7 dagen, om 14:52 | ||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Reden afspraak | Opname | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||
MBH identificatie | MBH_513_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 5 dagen, om 09:45 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Aanvullende informatie | Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
Toelichting | Wegens niet leverbaar zijn van Broxil | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Verstrekkingen XXX_Amaya
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Aanschrijfdatum | T, om 14:32 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_513_2_VV_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Datum | T- 5 dagen, om 09:45 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende informatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
Toelichting | Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
Relatie naar verstrekkingsverzoek | MBH_513_4_VV_1 | ||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Amaya
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 2 dagen, om 15:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 2 dagen, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:40 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 1 dag, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 21:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 3 dagen, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Gerelateerde afspraak : MA | MBH_513_3_MA_1 | ||
Auteur | Patiënt | ||
Reden gebruik | Lymfekanker | ||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 4 dagen, om 22:35 | ||
Gebruik indicator | true | ||
Volgens afspraak indicator | false | ||
Gebruiksperiode | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_513_4 |
Patiënt Pauline P. XXX_Bourgonje
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Bourgonje
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 1 dag, om 11:25 | ||
Gebruiksperiode | Vanaf T- 1 dag, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 10 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 09:00 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 5 dagen, om 09:35 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Lichaamslengte | 155 | ||
Lichaamsgewicht | 54 | ||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_513_4 |
Verstrekkingsverzoeken XXX_Bourgonje
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | 2018-08-16T14:32:00 | ||
Auteur | Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
Te verstrekken hoeveelheid | 30 stuks | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Toelichting | nog in te vullen, zie word... | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | T- 5 dagen, om 09:35 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 40 stuks | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende wensen | Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Toedieningsafspraken XXX_Bourgonje
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T, om 12:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||
MBH identificatie | MBH_513_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 7 dagen, om 14:52 | ||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Reden afspraak | Opname | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||
MBH identificatie | MBH_513_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 5 dagen, om 09:45 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Aanvullende informatie | Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
Toelichting | Wegens niet leverbaar zijn van Broxil | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Verstrekkingen XXX_Bourgonje
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Aanschrijfdatum | T, om 14:32 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_513_2_VV_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Datum | T- 5 dagen, om 09:45 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende informatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
Toelichting | Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
Relatie naar verstrekkingsverzoek | MBH_513_4_VV_1 | ||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Bourgonje
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 2 dagen, om 15:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 2 dagen, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:40 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 1 dag, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 21:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 3 dagen, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Gerelateerde afspraak : MA | MBH_513_3_MA_1 | ||
Auteur | Patiënt | ||
Reden gebruik | Lymfekanker | ||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 4 dagen, om 22:35 | ||
Gebruik indicator | true | ||
Volgens afspraak indicator | false | ||
Gebruiksperiode | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_513_4 |
Patiënt J. XXX_Cnossen
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Cnossen
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 1 dag, om 11:25 | ||
Gebruiksperiode | Vanaf T- 1 dag, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 10 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 09:00 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 5 dagen, om 09:35 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Lichaamslengte | 155 | ||
Lichaamsgewicht | 54 | ||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_513_4 |
Toedieningsafspraken XXX_Cnossen
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T, om 12:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||
MBH identificatie | MBH_513_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 7 dagen, om 14:52 | ||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Reden afspraak | Opname | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||
MBH identificatie | MBH_513_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 5 dagen, om 09:45 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Aanvullende informatie | Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
Toelichting | Wegens niet leverbaar zijn van Broxil | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Cnossen
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 2 dagen, om 15:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 2 dagen, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:40 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 1 dag, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 21:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 3 dagen, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Gerelateerde afspraak : MA | MBH_513_3_MA_1 | ||
Auteur | Patiënt | ||
Reden gebruik | Lymfekanker | ||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 4 dagen, om 22:35 | ||
Gebruik indicator | true | ||
Volgens afspraak indicator | false | ||
Gebruiksperiode | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_513_4 |
Patiënt R. XXX_Dirksz
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Dirksz
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 1 dag, om 11:25 | ||
Gebruiksperiode | Vanaf T- 1 dag, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 10 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 09:00 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 5 dagen, om 09:35 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Lichaamslengte | 155 | ||
Lichaamsgewicht | 54 | ||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_513_4 |
Verstrekkingsverzoeken XXX_Dirksz
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | 2018-08-16T14:32:00 | ||
Auteur | Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
Te verstrekken hoeveelheid | 30 stuks | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Toelichting | nog in te vullen, zie word... | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | T- 5 dagen, om 09:35 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 40 stuks | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende wensen | Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Toedieningsafspraken XXX_Dirksz
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T, om 12:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||
MBH identificatie | MBH_513_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 7 dagen, om 14:52 | ||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Reden afspraak | Opname | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||
MBH identificatie | MBH_513_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 5 dagen, om 09:45 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Aanvullende informatie | Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
Toelichting | Wegens niet leverbaar zijn van Broxil | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Verstrekkingen XXX_Dirksz
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Aanschrijfdatum | T, om 14:32 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_513_2_VV_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Datum | T- 5 dagen, om 09:45 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende informatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
Toelichting | Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
Relatie naar verstrekkingsverzoek | MBH_513_4_VV_1 | ||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Dirksz
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 2 dagen, om 15:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 2 dagen, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:40 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 1 dag, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 21:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 3 dagen, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Gerelateerde afspraak : MA | MBH_513_3_MA_1 | ||
Auteur | Patiënt | ||
Reden gebruik | Lymfekanker | ||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 4 dagen, om 22:35 | ||
Gebruik indicator | true | ||
Volgens afspraak indicator | false | ||
Gebruiksperiode | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_513_4 |
Patiënt R. XXX_Gobee
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Gobee
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 1 dag, om 11:25 | ||
Gebruiksperiode | Vanaf T- 1 dag, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 10 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 09:00 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 5 dagen, om 09:35 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Lichaamslengte | 155 | ||
Lichaamsgewicht | 54 | ||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_513_4 |
Verstrekkingsverzoeken XXX_Gobee
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | 2018-08-16T14:32:00 | ||
Auteur | Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
Te verstrekken hoeveelheid | 30 stuks | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Toelichting | nog in te vullen, zie word... | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | T- 5 dagen, om 09:35 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 40 stuks | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende wensen | Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Toedieningsafspraken XXX_Gobee
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T, om 12:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||
MBH identificatie | MBH_513_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 7 dagen, om 14:52 | ||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Reden afspraak | Opname | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||
MBH identificatie | MBH_513_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 5 dagen, om 09:45 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Aanvullende informatie | Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
Toelichting | Wegens niet leverbaar zijn van Broxil | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Verstrekkingen XXX_Gobee
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Aanschrijfdatum | T, om 14:32 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_513_2_VV_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Datum | T- 5 dagen, om 09:45 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende informatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
Toelichting | Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
Relatie naar verstrekkingsverzoek | MBH_513_4_VV_1 | ||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Gobee
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 2 dagen, om 15:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 2 dagen, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:40 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 1 dag, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 21:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 3 dagen, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Gerelateerde afspraak : MA | MBH_513_3_MA_1 | ||
Auteur | Patiënt | ||
Reden gebruik | Lymfekanker | ||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 4 dagen, om 22:35 | ||
Gebruik indicator | true | ||
Volgens afspraak indicator | false | ||
Gebruiksperiode | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_513_4 |
Patiënt J. XXX_Kilkenny
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Kilkenny
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 1 dag, om 11:25 | ||
Gebruiksperiode | Vanaf T- 1 dag, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 10 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 09:00 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 5 dagen, om 09:35 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Lichaamslengte | 155 | ||
Lichaamsgewicht | 54 | ||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Kilkenny
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 2 dagen, om 15:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 2 dagen, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:40 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 1 dag, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 21:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 3 dagen, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Gerelateerde afspraak : MA | MBH_513_3_MA_1 | ||
Auteur | Patiënt | ||
Reden gebruik | Lymfekanker | ||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 4 dagen, om 22:35 | ||
Gebruik indicator | true | ||
Volgens afspraak indicator | false | ||
Gebruiksperiode | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_513_4 |
Patiënt R. XXX_Ruys
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Patiënt R. XXX_Strengersz
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Strengersz
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 1 dag, om 11:25 | ||
Gebruiksperiode | Vanaf T- 1 dag, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 10 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 09:00 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Afspraakdatum | T- 5 dagen, om 09:35 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Lichaamslengte | 155 | ||
Lichaamsgewicht | 54 | ||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_513_4 |
Verstrekkingsverzoeken XXX_Strengersz
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_VV_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | 2018-08-16T14:32:00 | ||
Auteur | Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
Te verstrekken hoeveelheid | 30 stuks | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Toelichting | nog in te vullen, zie word... | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
Datum | T- 5 dagen, om 09:35 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 40 stuks | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende wensen | Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Toedieningsafspraken XXX_Strengersz
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T, om 12:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Geannuleerd indicator | true | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||
MBH identificatie | MBH_513_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 7 dagen, om 14:52 | ||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Reden afspraak | Opname | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||
MBH identificatie | MBH_513_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
Afspraakdatum | T- 5 dagen, om 09:45 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Aanvullende informatie | Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
Toelichting | Wegens niet leverbaar zijn van Broxil | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Verstrekkingen XXX_Strengersz
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Aanschrijfdatum | T, om 14:32 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_513_2_VV_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
Datum | T- 5 dagen, om 09:45 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende informatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
Toelichting | Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
Relatie naar verstrekkingsverzoek | MBH_513_4_VV_1 | ||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Strengersz
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 2 dagen, om 15:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 2 dagen, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:40 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 1 dag, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 21:39 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 3 dagen, om 20:59 | ||
Gebruik indicator | true | ||
Gebruiksperiode | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Gerelateerde afspraak : MA | MBH_513_3_MA_1 | ||
Auteur | Patiënt | ||
Reden gebruik | Lymfekanker | ||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | ||
Registratiedatum | T- 4 dagen, om 22:35 | ||
Gebruik indicator | true | ||
Volgens afspraak indicator | false | ||
Gebruiksperiode | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_513_4 |